1. Cefoperazone: a review of its antimicrobial spectrum, beta-lactamase stability, enzyme inhibition, and other in vitro characteristics;Jones;Rev. Infect. Dis.,1983
2. U.S. Food and Drug Administration, CEFOBID® (sterile cefoperazone) For Intravenous or Intramuscular Use. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050551s045lbl.pdf (19 November 2019).
3. beta-Lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone;Williams;Clin. Infect. Dis.,1997
4. National Health Commission of the People's Republic of China, Guideline for the clinical application of antimicrobial agents (2015). http://www.nhc.gov.cn/ewebeditor/uploadfile/2015/09/20150928170007470.pdf (19 November 2019).
5. Study Group of Biliary Tract Surgery in Chinese Society of Surgery of Chinese Medical Association, Enhanced Recovery After Surgery Committee of Chinese Research Hospital Association, Editorial Board Chinese Journal Surgery. Surgery, A consensus statement on the standardized application of antibacterial agents in biliary tract surgery (2019), Chin J Surg, 57 (2019). https://dx.doi.org/10.3760/cma.j.issn.0529-5815.2019.07.001.